Favism and glucose-6-phosphate dehydrogenase deficiency

L Luzzatto, P Arese - New England Journal of Medicine, 2018 - Mass Medical Soc
Favism and Glucose-6-Phosphate Dehydrogenase Deficiency When persons with G6PD
deficiency eat fava beans, acute hemolytic anemia may develop. It is caused by the …

[HTML][HTML] Age-specific malaria seroprevalence rates: a cross-sectional analysis of malaria transmission in the Ouest and Sud-Est departments of Haiti

ME von Fricken, TA Weppelmann, B Lam, WT Eaton… - Malaria journal, 2014 - Springer
Background Malaria transmission continues to occur in Haiti, with 25,423 confirmed cases of
Plasmodium falciparum and 161,236 suspected infections reported in 2012. At low …

Validation of transcutaneous bilirubinometry during phototherapy for detection and monitoring of neonatal jaundice in a low-income setting

SM Johnson, V Vasu, C Marseille, C Hill… - Paediatrics and …, 2020 - Taylor & Francis
Background: Severe neonatal jaundice (SNJ) and the associated long-term health sequelae
are a significant problem in low-income countries (LIC) where measurement of total serum …

[HTML][HTML] Performance of the CareStart glucose-6-phosphate dehydrogenase (G6PD) rapid diagnostic test in Gressier, Haiti

ME von Fricken, TA Weppelmann… - The American journal …, 2014 - ncbi.nlm.nih.gov
Administering primaquine (PQ) to treat malaria patients with glucose-6-phosphate
dehydrogenase (G6PD) deficiency can pose a serious risk of drug-induced hemolysis (DIH) …

[HTML][HTML] Field trial of the CareStart biosensor analyzer for the determination of glucose-6-phosphate dehydrogenase activity in Haiti

TA Weppelmann, ME von Fricken… - The American journal …, 2017 - ncbi.nlm.nih.gov
Throughout many developing and tropical countries around the world, malaria remains a
significant threat to human health. One barrier to malaria elimination is the ability to safely …

[HTML][HTML] Prevalence of glucose-6-phosphate dehydrogenase deficiency (G6PDd) and clinical implication for safe use of primaquine in malaria-endemic areas of …

W Zeng, N Liu, Y Li, A Gao, M Yuan, R Ma… - Frontiers in Public …, 2022 - frontiersin.org
Primaquine, the only licensed antimalarial drug for eradication of Plasmodium vivax and
Plasmodium ovale malaria, may cause acute hemolytic anemia in individuals with glucose-6 …

Identification of Glucose-6 Phosphate Dehydrogenase Deficient Patients Using Attenuated Total Reflection Fourier Transform Infrared Spectroscopy Using Partial …

M Martin, M Wongwattanakul… - Applied …, 2023 - journals.sagepub.com
Glucose-6 phosphate dehydrogenase (G6PD) deficiency is an X-linked blood disease that
affects 400 million people globally and is especially prevalent in malaria-endemic regions. A …

[HTML][HTML] Glucose-6-Phosphate Dehydrogenase Deficiency A− Variant in Febrile Patients in Haiti

TE Carter, H Maloy, M von Fricken… - The American journal …, 2014 - ncbi.nlm.nih.gov
Haiti is one of two remaining malaria-endemic countries in the Caribbean. To decrease
malaria transmission in Haiti, primaquine was recently added to the malaria treatment public …

Cross-sectional analysis of the association between bedtime and malaria exposure in the Ouest and Sud-Est Departments of Haiti

CJ Stephenson, ME Rossheim, CL Frankenfeld… - Acta tropica, 2017 - Elsevier
Abstract Introduction The governments of Haiti and the Dominican Republic have a
binational agreement to work towards malaria elimination for the island of Hispaniola by the …

[PDF][PDF] Déficit en glucose-6-phosphate déshydrogénase: À propos de 54 cas

MZ Saoud, S Benkirane, FZ Bennis, Y Mechal… - Hématologie, 2019 - researchgate.net
Le déficit en glucose-6-phosphate déshydrogénase (G6PD) est le déficit enzymatique le
plus répandu à travers le monde. Il est causé par des mutations au niveau du gène G6PD …